Advanced/Metastatic
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma (NCT07283731) | M.D. Anderson Cancer Center | 2026-04-14 |
| Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC (NCT07641023) | Beijing Biotech | 2026-03-02 |
Track Advanced/Metastatic automatically
Every clearance here is in the API, with alerts when new ones post.